An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Pearce FA, Lim SH, Bythell M, Lanyon P, Hogg R, Taylor A, et al. Antibody Prevalence after Three or More COVID-19 Vaccine Doses in Individuals Who Are Immunosuppressed in the UK: A Cross-Sectional Study from MELODY. Lancet Rheumatol (2023) 5:e461–e473. 10.1016/S2665-9913(23)00160-1
-
DOI
-
PubMed
Pascual J, Royuela A, Galeano C, Crespo M, Zamora J. Very Early Steroid Withdrawal or Complete Avoidance for Kidney Transplant Recipients: A Systematic Review. Nephrol Dial Transplant (2012) 27:825–32. 10.1093/ndt/gfr374
-
DOI
-
PubMed
Karpe KM, Talaulikar GS, Walters GD. Calcineurin Inhibitor Withdrawal or Tapering for Kidney Transplant Recipients. Cochrane Database Syst Rev (2017) 7:CD006750. 10.1002/14651858.CD006750.pub2
-
DOI
-
PMC
-
PubMed
de Weerd AE, Fatly ZA, Boer-Verschragen M, Kal-van Gestel JA, Roelen DL, Dieterich M, et al. Tacrolimus Monotherapy Is Safe in Immunologically Low-Risk Kidney Transplant Recipients: A Randomized-Controlled Pilot Study. Transpl Int (2022) 35:10839. 10.3389/ti.2022.10839
-
DOI
-
PMC
-
PubMed
Fatly ZA, Betjes MGH, Dik WA, Fouchier RAM, Reinders MEJ, de Weerd AE. Mycophenolate Mofetil Hampers Antibody Responses to a Broad Range of Vaccinations in Kidney Transplant Recipients: Results from a Randomized Controlled Study. J Infect (2024) 88:106133. 10.1016/j.jinf.2024.106133
-
DOI
-
PubMed